BG102215A - Compounds and pharmaceutical compositions containing them - Google Patents
Compounds and pharmaceutical compositions containing themInfo
- Publication number
- BG102215A BG102215A BG102215A BG10221598A BG102215A BG 102215 A BG102215 A BG 102215A BG 102215 A BG102215 A BG 102215A BG 10221598 A BG10221598 A BG 10221598A BG 102215 A BG102215 A BG 102215A
- Authority
- BG
- Bulgaria
- Prior art keywords
- compounds
- pharmaceutical compositions
- compositions containing
- formulawhich
- aminophosphonates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical group NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01920/95A CH690264A5 (fr) | 1995-06-30 | 1995-06-30 | Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques. |
PCT/EP1996/002842 WO1997002037A1 (en) | 1995-06-30 | 1996-06-26 | Compounds and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102215A true BG102215A (en) | 1998-09-30 |
Family
ID=4221681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102215A BG102215A (en) | 1995-06-30 | 1998-01-28 | Compounds and pharmaceutical compositions containing them |
Country Status (27)
Country | Link |
---|---|
US (2) | US6060464A (no) |
EP (1) | EP0835116A1 (no) |
JP (1) | JPH11508576A (no) |
KR (1) | KR19990028542A (no) |
CN (1) | CN1113654C (no) |
AP (1) | AP778A (no) |
AR (1) | AR004498A1 (no) |
AU (1) | AU705206B2 (no) |
BG (1) | BG102215A (no) |
BR (1) | BR9609653A (no) |
CA (1) | CA2225391A1 (no) |
CH (1) | CH690264A5 (no) |
CZ (1) | CZ422097A3 (no) |
EA (1) | EA199800106A1 (no) |
HU (1) | HUP9901684A3 (no) |
IL (1) | IL122717A0 (no) |
MA (1) | MA24340A1 (no) |
MX (1) | MX9800189A (no) |
NO (1) | NO976128L (no) |
NZ (1) | NZ312696A (no) |
OA (1) | OA10554A (no) |
PL (1) | PL187024B1 (no) |
SK (1) | SK178397A3 (no) |
TR (1) | TR199701700T1 (no) |
TW (1) | TW413681B (no) |
WO (1) | WO1997002037A1 (no) |
ZA (1) | ZA965505B (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
GB9626536D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
GB9626615D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
GB9626616D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
DE19748659A1 (de) * | 1997-11-04 | 1999-05-06 | Hoechst Ag | Aminophosphoniumgruppen enthaltende vernetzte Copolymere für medizinische Verwendungen |
US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
US6284795B1 (en) | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
WO2001030339A1 (en) | 1999-10-27 | 2001-05-03 | Teva Pharmaceutical Industries, Ltd. | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
EP1263740B1 (en) | 2000-02-16 | 2006-07-19 | SmithKline Beecham plc | Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
US20030114421A1 (en) * | 2000-09-27 | 2003-06-19 | Phan Hieu Trung | Alpha-substituted beta-aminoethyl phosphonate derivatives |
JP2004513891A (ja) | 2000-09-27 | 2004-05-13 | アイレックス オンコロジー リサーチ エス.エイ. | α−置換β−アミノエチルホスホネート |
GB0024808D0 (en) | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
GB0025849D0 (en) * | 2000-10-23 | 2000-12-06 | Smithkline Beecham Plc | Novel compounds |
EP1482953A4 (en) * | 2002-02-11 | 2006-12-13 | Ilex Products Inc | ALPHA-SUBSTITUTED HETEROARYL ALKYL PHOSPHONATE DERIVATIVES |
US20060128667A1 (en) * | 2002-05-11 | 2006-06-15 | Montes Imber F | Hydroxyphosphonates and phosphonophosphates as apolipoprotein e modulators |
WO2004019889A2 (en) * | 2002-08-30 | 2004-03-11 | Biostratum, Inc. | Inhibitors of post-amadori advanced glycation end products |
KR101861883B1 (ko) | 2010-12-06 | 2018-05-28 | 글락소 그룹 리미티드 | Lp-PLA₂에 의해 매개되는 질환 또는 상태의 치료에 사용하기 위한 피리미디논 화합물 |
UY34216A (es) | 2011-07-27 | 2013-02-28 | Glaxo Group Ltd | Nuevos compuestos que inhiben la actividad de la Lp-PLA2 |
CA2842965A1 (en) | 2011-07-27 | 2013-01-31 | Glaxo Group Limited | 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors |
EP2751094B1 (en) | 2011-09-01 | 2018-06-20 | Glaxo Group Limited | Novel crystal form |
KR20150108897A (ko) | 2013-01-25 | 2015-09-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 2,3-디히드로이미다졸[1,2-c]피리미딘-5(1h)-온계의 지단백질-연관 포스포리파제 a2 (lp-pla2) 억제제 |
KR20150111356A (ko) | 2013-01-25 | 2015-10-05 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 화합물 |
AU2014210260B2 (en) | 2013-01-25 | 2016-08-04 | Glaxosmithkline Intellectual Property Development Limited | Bicyclic pyrimidone compounds as inhibitors of Lp-PLA2 |
WO2016012917A1 (en) | 2014-07-22 | 2016-01-28 | Glaxosmithkline Intellectual Property Development Limited | 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2 |
WO2016012916A1 (en) | 2014-07-22 | 2016-01-28 | Glaxosmithkline Intellectual Property Development Limited | 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2 |
CN112778331B (zh) | 2019-11-09 | 2022-07-05 | 上海赛默罗生物科技有限公司 | 三环二氢咪唑并嘧啶酮衍生物、其制备方法、药物组合物和用途 |
CN115304620A (zh) | 2021-05-07 | 2022-11-08 | 上海赛默罗生物科技有限公司 | 嘧啶酮衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH683996A5 (fr) * | 1992-03-05 | 1994-06-30 | Symphar Sa | Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant. |
DE4433244A1 (de) * | 1994-09-19 | 1996-03-28 | Hoechst Ag | Aminomethylphosphon- und Aminomethylphosphinsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen |
-
1995
- 1995-06-30 CH CH01920/95A patent/CH690264A5/fr not_active IP Right Cessation
-
1996
- 1996-06-26 CN CN96196395A patent/CN1113654C/zh not_active Expired - Fee Related
- 1996-06-26 AP APAP/P/1997/001160A patent/AP778A/en active
- 1996-06-26 EA EA199800106A patent/EA199800106A1/ru unknown
- 1996-06-26 KR KR1019970709860A patent/KR19990028542A/ko not_active Application Discontinuation
- 1996-06-26 JP JP9504801A patent/JPH11508576A/ja not_active Withdrawn
- 1996-06-26 AU AU64185/96A patent/AU705206B2/en not_active Ceased
- 1996-06-26 SK SK1783-97A patent/SK178397A3/sk unknown
- 1996-06-26 TR TR97/01700T patent/TR199701700T1/xx unknown
- 1996-06-26 WO PCT/EP1996/002842 patent/WO1997002037A1/en not_active Application Discontinuation
- 1996-06-26 CA CA002225391A patent/CA2225391A1/en not_active Abandoned
- 1996-06-26 BR BR9609653-5A patent/BR9609653A/pt not_active Application Discontinuation
- 1996-06-26 IL IL12271796A patent/IL122717A0/xx unknown
- 1996-06-26 EP EP96923971A patent/EP0835116A1/en not_active Withdrawn
- 1996-06-26 CZ CZ974220A patent/CZ422097A3/cs unknown
- 1996-06-26 MX MX9800189A patent/MX9800189A/es unknown
- 1996-06-26 US US08/973,669 patent/US6060464A/en not_active Expired - Fee Related
- 1996-06-26 HU HU9901684A patent/HUP9901684A3/hu unknown
- 1996-06-26 NZ NZ312696A patent/NZ312696A/en unknown
- 1996-06-26 PL PL96324341A patent/PL187024B1/pl unknown
- 1996-06-28 MA MA24297A patent/MA24340A1/fr unknown
- 1996-06-28 AR ARP960103399A patent/AR004498A1/es unknown
- 1996-06-28 ZA ZA9605505A patent/ZA965505B/xx unknown
- 1996-07-01 TW TW085107922A patent/TW413681B/zh not_active IP Right Cessation
-
1997
- 1997-12-29 NO NO976128A patent/NO976128L/no not_active Application Discontinuation
- 1997-12-30 OA OA70171A patent/OA10554A/en unknown
-
1998
- 1998-01-28 BG BG102215A patent/BG102215A/xx unknown
-
2000
- 2000-04-03 US US09/541,217 patent/US6660724B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EA199800106A1 (ru) | 1998-08-27 |
AP9701160A0 (en) | 1998-01-31 |
AR004498A1 (es) | 1998-12-16 |
MX9800189A (es) | 1998-04-30 |
IL122717A0 (en) | 1998-08-16 |
OA10554A (en) | 2002-05-29 |
EP0835116A1 (en) | 1998-04-15 |
CZ422097A3 (cs) | 1998-10-14 |
AU6418596A (en) | 1997-02-05 |
US6060464A (en) | 2000-05-09 |
ZA965505B (en) | 1998-03-30 |
JPH11508576A (ja) | 1999-07-27 |
NZ312696A (en) | 1999-10-28 |
US6660724B1 (en) | 2003-12-09 |
PL324341A1 (en) | 1998-05-25 |
CN1193913A (zh) | 1998-09-23 |
AP778A (en) | 1999-10-29 |
CA2225391A1 (en) | 1997-01-23 |
WO1997002037A1 (en) | 1997-01-23 |
CH690264A5 (fr) | 2000-06-30 |
BR9609653A (pt) | 1999-12-21 |
TR199701700T1 (xx) | 1998-03-21 |
CN1113654C (zh) | 2003-07-09 |
NO976128D0 (no) | 1997-12-29 |
PL187024B1 (pl) | 2004-04-30 |
TW413681B (en) | 2000-12-01 |
NO976128L (no) | 1998-02-10 |
MA24340A1 (fr) | 1998-07-01 |
KR19990028542A (ko) | 1999-04-15 |
AU705206B2 (en) | 1999-05-20 |
HUP9901684A2 (hu) | 1999-09-28 |
HUP9901684A3 (en) | 2000-04-28 |
SK178397A3 (en) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG102215A (en) | Compounds and pharmaceutical compositions containing them | |
IL105715A0 (en) | 7beta substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions containing them | |
IL115790A0 (en) | Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof | |
BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
UA34428C2 (uk) | Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки | |
IL128425A0 (en) | Taxane derivatives their preparation and pharmaceutical compositions containing them | |
IL126038A0 (en) | Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them | |
ZA933768B (en) | Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism. | |
ZA98214B (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. | |
AU658296B2 (en) | 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors | |
PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
EP0353678A3 (en) | FR-901154 and FR-901155 substances, a process for their production | |
BG103968A (en) | Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity | |
IL110201A0 (en) | Novel pharmaceutical compositions | |
AU3481795A (en) | Pharmaceutical compositions containing d2o | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
AU1343388A (en) | Iodinated polymers | |
AU6849198A (en) | Neurotrypsin | |
IL128500A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AU4609693A (en) | An interferon-alpha/beta binding protein its preparation and pharmaceutical compositions containing it | |
FI923751A0 (fi) | Hexahydrobenso/f/kinolinoner. | |
GR3029794T3 (en) | Hydrolytically stable pentaerythritol diphosphites. | |
BG101163A (en) | 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them | |
BG104373A (en) | Polymorphous forms of dofetilide |